---
title: "600332.SH (600332.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600332.SH/news.md"
symbol: "600332.SH"
name: "600332.SH"
parent: "https://longbridge.com/en/quote/600332.SH.md"
datetime: "2026-05-20T12:02:58.569Z"
locales:
  - [en](https://longbridge.com/en/quote/600332.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600332.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600332.SH/news.md)
---

# 600332.SH (600332.SH) — Related News

### [Can Guangzhou Pharmaceutical's Wanglaoji regain its peak by acquiring a century-old pharmaceutical company and entering the hospital market?](https://longbridge.com/en/news/286754154.md)
*2026-05-18T10:13:18.000Z*
> Guangyao Wanglaoji recently acquired a century-old pharmaceutical company and plans to enter the hospital market, aiming

### [Guangyao Group jointly established the "14th Five-Year Plan" Traditional Chinese Medicine Industry High-Quality Development Community](https://longbridge.com/en/news/286661855.md)
*2026-05-17T05:16:10.000Z*
> From May 15 to 17, the Health China and Biopharmaceutical Engineering Innovation Seminar and the Fifth High-Quality Deve

### [BAIYUNSHAN PH: Liu Hong was elected as the employee representative director of the 10th Board of Directors](https://longbridge.com/en/news/286543611.md)
*2026-05-15T10:03:03.000Z*
> BAIYUNSHAN PH announced that Mr. Liu Hong has been elected as the employee representative director of the 10th Board of 

### [Who earned the most? The ranking of net profits of traditional Chinese medicine listed companies in 2025 is revealed](https://longbridge.com/en/news/286340296.md)
*2026-05-14T01:25:12.000Z*
> Who earned the most? The ranking of net profits of traditional Chinese medicine listed companies in 2025 is revealed

### [BAIYUNSHAN PH: Tianxin Pharmaceutical has obtained the "Drug Supplement Application Approval Notice" for Cefuroxime Sodium Injection 0.5g and Candesartan Cilexetil Tablets 4mg](https://longbridge.com/en/news/285915602.md)
*2026-05-11T09:38:05.000Z*
> BAIYUNSHAN PH's subsidiary Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. recently received the "Drug Supplement 

### [BAIYUNSHAN PH: Suggests re-election and election of directors](https://longbridge.com/en/news/285560632.md)
*2026-05-07T13:18:03.000Z*
> BAIYUNSHAN PH announced that the 35th meeting of the 9th Board of Directors will be held on May 7, 2026, to review and n

### [BAIYUNSHAN PH Hanfang Global Investment Promotion has completed strategic agreements with multiple partners](https://longbridge.com/en/news/285162535.md)
*2026-05-05T06:33:10.000Z*
> Guangyao Baiyunshan held a global investment promotion conference in Guangzhou on May 2, announcing investment policies 

### [A large number of OTC price reductions, chain pharmacies are having a tough time](https://longbridge.com/en/news/285051531.md)
*2026-05-04T09:27:29.000Z*
> On April 30th, the fourth batch of national Chinese patent medicine alliance procurement opened bidding in Wuhan, for th

### [Guangyao Group's Wanglaoji and Hanfang collaborate to go overseas](https://longbridge.com/en/news/285029978.md)
*2026-05-04T05:13:30.000Z*
> On May 2nd, Guangzhou Pharmaceutical Group's listed company GYBYS (600332) has two core enterprises: Guangzhou Wanglaoji

### [Guangyao Group ranks among the top 15 global pharmaceutical brand values, with a brand value exceeding 3 billion USD](https://longbridge.com/en/news/284862090.md)
*2026-05-01T02:54:21.000Z*
> Guangyao Group ranked 15th in the "Brand Finance 2026 Global Pharmaceutical Brand Value List," with a brand value exceed